about
Transgenic Mouse Bioassay: Evidence That Rabbits Are Susceptible to a Variety of Prion IsolatesC14ORF39/SIX6OS1 is a constituent of the synaptonemal complex and is essential for mouse fertilityMeiotic cohesin complexes are essential for the formation of the axial element in miceFUS-DDIT3 prevents the development of adipocytic precursors in liposarcoma by repressing PPARgamma and C/EBPalpha and activating eIF4E.Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia.Brain tumour stem cells: implications for cancer therapy and regenerative medicine.Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice.Cancer development induced by graded expression of Snail in mice.SLUG in cancer development.Long-term effects of mouse intracytoplasmic sperm injection with DNA-fragmented sperm on health and behavior of adult offspring.STAG3 is a strong candidate gene for male infertility.Fat-specific FUS-DDIT3-transgenic mice establish PPAR inactivation is required to liposarcoma developmentSplice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiencyLiposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcomaEstablishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technologyDogs are resistant to prion infection, due to the presence of aspartic or glutamic acid at position 163 of their prion proteinThe PSMA8 subunit of the spermatoproteasome is essential for proper meiotic exit and mouse fertilityExpression and functional analysis of the hydrogen peroxide biosensors HyPer and HyPer2 in C2C12 myoblasts/myotubes and single skeletal muscle fibres
P50
Q27318898-22591C68-0BE8-4B20-8ABD-339125EBD5ACQ28585210-43AC48BB-2D21-493A-A4E1-28D365B002D0Q28593387-184122BC-8EBE-4D1C-944F-C4895D20ED49Q33348653-5C19AA9F-E357-4A31-8693-356E797E569CQ33671442-0FFC43DC-DF6D-4F1F-96F4-99BF85A82E51Q33688509-27663F5F-D75C-4D8A-9CEF-01E18B97C6AFQ37264940-F837784D-C7D9-41AD-95FE-025AB64AC4BEQ40230301-65529E68-8BED-4C98-AC04-3E0FE5B46F41Q40365089-A0F2FB17-0867-4C28-AC5D-2079EB79B630Q40453569-7DCD0F89-CDE7-4935-ACC8-E7D42CD8FCBEQ42642531-7D29FB25-D5DC-4469-9F89-4818A1A50D12Q53063363-DD470B82-DCDE-4858-B9E0-5520374E43F5Q62057745-23A911A5-2B5B-49DF-8EAD-67F47D67FE2DQ64060862-C68749B4-EF02-4B4E-B98F-A00C9A55FF52Q73367499-DF7E044E-4A7F-4734-920C-0D92D509A4EEQ91944543-2D555138-F5C0-4647-9C9C-F7D7D95F1572Q92684861-2EFE6045-AE75-4E00-A6F9-8EFF30ED7505Q92773147-95B12B1A-9F45-4CFD-82A8-9ABFB688EFBEQ92824963-0E0EA312-3CD8-440D-877E-CF3D3C357B3F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Manuel Sanchez-Martin
@ast
Manuel Sanchez-Martin
@en
Manuel Sanchez-Martin
@es
Manuel Sanchez-Martin
@nl
Manuel Sanchez-Martin
@sl
type
label
Manuel Sanchez-Martin
@ast
Manuel Sanchez-Martin
@en
Manuel Sanchez-Martin
@es
Manuel Sanchez-Martin
@nl
Manuel Sanchez-Martin
@sl
prefLabel
Manuel Sanchez-Martin
@ast
Manuel Sanchez-Martin
@en
Manuel Sanchez-Martin
@es
Manuel Sanchez-Martin
@nl
Manuel Sanchez-Martin
@sl
P106
P21
P31
P496
0000-0001-8370-1336